BUY Cipla Ltd. — Madhu Bansal
byMadhu BansalHorizon: NA (inferred Swing (≤2wk))22 Jun 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·30 Jun · 6d ago
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·25 Jun · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cipla
- BUY — Ashish Bahety, Profitmart Securities29 Sept 2026 · Same day · target ₹1,420 · Expired
- BUY — Ashish Bahety, Profitmart Securities29 Sept 2026 · Same day · target ₹1,430 · Expired
- BUY — Rajesh Palviya, Axis Securities29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY — Arun Kumar Mantri28 Sept 2026 · ~1 year · target ₹1,900 · Active
- BUY — Arun Kumar Mantri25 Sept 2026 · Same day · target ₹1,428 · SL hit
More from Madhu Bansal
- BUY Supriya Lifescience29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY Supreme Petrochem29 Sept 2026 · ~2 weeks · target ₹957 · SL hit
- BUY Poonawalla Fincorp18 Sept 2026 · ~2 weeks · target ₹486 · Target hit
- BUY Prudent Corporate Advisory Services18 Sept 2026 · ~3 months · target ₹3,762 · SL hit
- BUY Sun Pharma Advanced Research Company17 Sept 2026 · ~2 weeks · target ₹208 · Target hit

